Align Technology Prevails in China Patent Infringement Action Against Angelalign

1 hour ago 4

Article content

SAN JOSE, Calif. & TEMPE, Ariz. — Align Technology, Inc. (“Align”) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, today announced that the Jinan Intermediate People’s Court in China issued a judgment in favor of Align in a patent infringement action against Angelalign Technology’s operating subsidiaries in China (“Angel”) (Hong Kong Stock Exchange: 6699.HK).

Financial Post

THIS CONTENT IS RESERVED FOR SUBSCRIBERS ONLY

Subscribe now to read the latest news in your city and across Canada.

  • Exclusive articles from Barbara Shecter, Joe O'Connor, Gabriel Friedman, and others.
  • Daily content from Financial Times, the world's leading global business publication.
  • Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.
  • National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.
  • Daily puzzles, including the New York Times Crossword.

SUBSCRIBE TO UNLOCK MORE ARTICLES

Subscribe now to read the latest news in your city and across Canada.

  • Exclusive articles from Barbara Shecter, Joe O'Connor, Gabriel Friedman and others.
  • Daily content from Financial Times, the world's leading global business publication.
  • Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.
  • National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.
  • Daily puzzles, including the New York Times Crossword.

REGISTER / SIGN IN TO UNLOCK MORE ARTICLES

Create an account or sign in to continue with your reading experience.

  • Access articles from across Canada with one account.
  • Share your thoughts and join the conversation in the comments.
  • Enjoy additional articles per month.
  • Get email updates from your favourite authors.

THIS ARTICLE IS FREE TO READ REGISTER TO UNLOCK.

Create an account or sign in to continue with your reading experience.

  • Access articles from across Canada with one account
  • Share your thoughts and join the conversation in the comments
  • Enjoy additional articles per month
  • Get email updates from your favourite authors

Sign In or Create an Account

or

Article content

In September 2025, Align filed a patent infringement action against Angel in the Jinan Intermediate People’s Court, asserting Align’s patent related to extraction-gap-closure technology (CN113693748B). On August 10, 2026, the Jinan Intermediate People’s Court issued a first-instance judgment finding that Angel’s use of its MasterForce biomechanical simulation system and ATreat digital orthodontic treatment design system to generate A7 and A7 Speed premolar extraction treatment solutions infringes Align’s patent rights. The court further found that the related aligner products manufactured and sold using the accused technology also infringe Align’s patent. Angel may appeal the judgment to the Supreme People’s Court. The deadline for filing an appeal has not yet expired.

Article content

Article content

Article content

The court ordered Angel to cease using the patented technology and to stop manufacturing and selling the infringing products in China and awarded Align RMB 10 million in damages. While the ruling remains subject to appeal, Align believes the decision further reinforces the strength of its intellectual property portfolio and ongoing commitment to protecting its innovations globally.

Article content

By signing up you consent to receive the above newsletter from Postmedia Network Inc.

Article content

The ruling follows other recent developments in Align’s patent-enforcement actions against Angel. In February 2026, the Unified Patent Court (“UPC”) issued a preliminary injunction requiring Angel to cease infringement of Align’s patented ClinCheck® Live Update technology, a decision that was subsequently upheld on appeal. In July 2026, the U.S. International Trade Commission (“ITC”) conducted an evidentiary hearing concerning five patents asserted by Align against Angel. Align expects that the ITC will make its initial determination regarding the merits of Align’s claims in November 2026. Align also continues to pursue additional patent infringement actions against Angel affiliates in China and Europe.

Article content

“Align has made significant long-term investments in innovation and in the Chinese market,” said Joe Hogan, president and chief executive officer of Align Technology. “We respect the role of China’s courts in protecting intellectual property rights and are encouraged by this decision. Protecting intellectual property is essential to sustaining that innovation and ensuring continued investment in technologies that benefit doctors and patients. This decision reinforces the value and strength of Align’s intellectual property portfolio and the significant investments we have made to develop industry-leading technologies. We remain committed to supporting fair competition, advancing innovation, and protecting our intellectual property rights while competing in the marketplace.”

Article content

Align’s Cutting-Edge Global Operations

Article content

As a global leader in digital orthodontics and restorative dentistry with nearly 23.5 million Invisalign® patients treated worldwide, Align continues to transform the orthodontic industry through its global operations, advanced manufacturing capabilities, and doctor-directed treatment planning.

Article content

Align’s operations span the Americas, EMEA, and APAC regions, with clinical treatment planning centers in Costa Rica, Poland, China (Chengdu), Spain, France, Germany, and Japan. The company’s global aligner manufacturing operations includes world-class facilities in Juarez, Mexico; Wroclaw, Poland; and Ziyang, China; Vienna, Austria; San Jose, CA; and a new aligner manufacturing facility coming online in 2027 in Hyderabad, India; together forming the backbone of the world’s largest 3D printing network for dental aligners (appliances).

Article content

Article content

Align’s investments in global operations are designed to bring its facilities closer to doctor-customers and their patients. In Mexico, the Juarez facility serves as a strategic node in Align’s global supply chain, enabling fast and cost-effective delivery of aligners to customers in the U.S., Canada, Latin America, and beyond. In China, the Chengdu treatment planning center and Ziyang manufacturing facility are central to Align’s long-term investment strategy for China, supporting the local economy and one of its fastest-growing markets by helping Chinese doctors provide millions of Chinese consumers access to high-quality orthodontic care. Wroclaw, Poland is the operations hub for Align’s EMEA business, bringing operations and support closer to the more than 63,000 Invisalign-trained doctors in the region.

Article content

About Align Technology, Inc.

Article content

Align Technology designs and manufactures the Invisalign® System, the most advanced clear aligner system in the world, iTero™ intraoral scanners and services, and exocad™ CAD/CAM software. These technology building blocks enable enhanced digital orthodontic and restorative workflows to improve patient outcomes and practice efficiencies for over 302.0 thousand doctor customers and are key to accessing Align’s 600 million consumer market opportunity worldwide. Over the past 29 years, Align has helped doctors treat approximately 23.5 million patients with the Invisalign System and is driving the evolution in digital dentistry through the Align™ Digital Platform, our integrated suite of unique, proprietary technologies and services delivered as a seamless, end-to-end solution for patients and consumers, orthodontists and GP dentists, and lab/partners. Visit www.aligntech.com for more information.

Article content

For additional information about the Invisalign system or to find an Invisalign doctor in your area, please visit www.invisalign.com. For additional information about the iTero digital scanning system, please visit www.itero.com. For additional information about exocad dental CAD/CAM offerings and a list of exocad reseller partners, please visit www.exocad.com.

Article content

Invisalign, iTero, exocad, Align, Align Digital Platform and iTero Lumina are trademarks of Align Technology, Inc.

Article content

Article content

Article content

Article content

View source version on businesswire.com:

Article content

Article content

logo

Article content

Contacts

Article content

Align Technology

Article content

Article content

Madelyn Valente

Article content

Article content

(909) 833-5839

Article content

Article content

Article content

Zeno Group

Article content

Article content

Sarah Karlson

Article content

Article content

(828) 551-4201

Article content

Article content

Article content

Read Entire Article